Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 7, 2020
Previous Article Next Article

An overview on the biosynthesis and metabolic regulation of monacolin K/lovastatin

Author affiliations

Abstract

Lovastatin/monacolin K (MK) is used as a lipid lowering drug, due to its effective hypercholesterolemic properties, comparable to synthetic statins. Lovastatin's biosynthetic pathway and gene cluster composition have been studied in depth in Aspergillus terreus. Evidence shows that the MK biosynthetic pathway and gene cluster in Monascus sp. are similar to those of lovastatin in A. terreus. Currently, research efforts have been focusing on the metabolic regulation of MK/lovastatin synthesis, and the evidence shows that a combination of extracellular and intracellular factors is essential for proper MK/lovastatin metabolism. Here, we comprehensively review the research progress on MK/lovastatin biosynthetic pathways, its synthetic precursors and inducing substances and metabolic regulation, with a view to providing reference for future research on fungal metabolism regulation and metabolic engineering for MK/lovastatin production.

Graphical abstract: An overview on the biosynthesis and metabolic regulation of monacolin K/lovastatin

Back to tab navigation

Article information


Submitted
17 Mar 2020
Accepted
26 May 2020
First published
26 May 2020

Food Funct., 2020,11, 5738-5748
Article type
Review Article

An overview on the biosynthesis and metabolic regulation of monacolin K/lovastatin

Y. Zhang, Z. Chen, Q. Wen, Z. Xiong, X. Cao, Z. Zheng, Y. Zhang and Z. Huang, Food Funct., 2020, 11, 5738
DOI: 10.1039/D0FO00691B

Social activity

Search articles by author

Spotlight

Advertisements